Alendronate therapy of primary hyperparathyroidism

Endocrinologist

Volumn 11, Issue 6, 2001, Pages 459-464

  Hassani, Sima ^a   Braunstein, Glenn D ^b   Seibel, Markus J ^c   Brickman, Arnold S ^b   Geola, Flor ^d   Pekary, A Eugene ^e   Hershman, Jerome M ^e  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Department of Microbiology and Infectious Diseases   (Australia)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALENDRONIC ACID; ALKALINE PHOSPHATASE; BISPHOSPHONIC ACID DERIVATIVE; CALCIFEDIOL; CALCITRIOL; CALCIUM ION; DEOXYPYRIDINOLINE; PARATHYROID HORMONE; PHOSPHORUS; PYRIDINOLINE;

ABDOMINAL DISCOMFORT; ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; BONE DENSITY; BONE TURNOVER; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; HEARTBURN; HUMAN; MALE; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; REVIEW;

EID: 0035205387     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019616-200111000-00006     Document Type: Review

References (28)

1. Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus Development Conference Statement
2. Asymptomatic primary hyperparathyroidism
3. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery
4. Primary hyperparathyroidism and the risk of fracture: A population based study
5. Medical management of asymptomatic primary hyperparathyroidism
6. Comparison of low dose intramuscular and intravenous salmon calcitonin in the treatment of primary hyperparathyroidism
7. Is estrogen preferable to surgery for post-menopausal women with primary hyperparathyroidism?
8. Effects of dichloromethylene diphosphonate on serum and urinary calcium in primary hyperparathyroidism
9. Acute changes in calcium homeostasis during treatment of primary hyperparathyroidism with residronate
10. Short-term inhibition of PTH hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism
11. Metabolic effects of diphosphonate in primary hyperparathyroidism
12. Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models
13. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis
14. Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
15. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism
16. Urinary hydroxypyridinium crosslinks of collagen reflect cartilage and bone involvement in rheumatic joint diseases
17. Standardization of pyridinium crosslinks, pyridinoline and deoxypyridinoline, for use of biochemical markers of collagen degradation
18. Surgery or no surgery for primary hyperparathyroidism
19. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism
20. Diphosphonate inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo
21. Clodronate in the medical management of hyperparathyroidism
22. Regulation of calciumparathyroid hormone feedback in primary hyperthyroidism in patients with primary hyperparathyroidism
23. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age
24. Estrogen replacement may be an alternative to parathyroid surgery for the treatment of osteoporosis in elderly postmenopausal women presenting with primary hyperparathyroidism: A preliminary report
25. Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism
26. Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure
27. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro
28. Primary hyperparathyroidism: Changes in trabecular bone remodeling following surgical treatment